about
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer'...
Read More1,767 XNAS Volume
XNAS 09 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Synaptogenix Inc is on 15 May 2025 for the purpose of Synaptogenix Inc First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Synaptogenix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..